1 Global Surgical Sutures Market Size (Value) and CAGR (2024-2033)
In 2024, the global Surgical Sutures market was valued at USD 4809.4 million, with a CAGR of 5.10% from 2024 to 2033.
Surgical sutures refer to medical devices used to hold body tissues together and help close wounds. Surgical sutures are often called sutures and include the use of needles with a certain length of thread. Surgical sutures used to suture wounds in various diseases (such as skin ulcers, neurological ulcers, pediatric cardiac surgery and diabetic ulcers). Surgical suture materials include natural and synthetic materials. Natural materials include silk, linen and gut, and synthetic materials include polyglycolic acid and polylactic acid.
Figure Global Surgical Sutures Market Size (M USD) and CAGR 2024-2033
2 Surgical Sutures Market Drivers
The global surgical sutures market is experiencing robust growth, driven by several key factors that are shaping the industry’s trajectory. One of the primary drivers is the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and neurological disorders. These conditions often necessitate surgical interventions, thereby boosting the demand for surgical sutures.
Another significant driver is the aging global population. As people live longer, the incidence of age-related health issues increases, leading to a higher demand for surgical procedures. This demographic shift is particularly pronounced in developed regions such as North America and Europe, where healthcare infrastructure is advanced, and the elderly population has better access to surgical treatments.
Technological advancements in the medical field are also propelling the market forward. Innovations in suture materials and techniques have led to the development of more effective and safer products. For example, the introduction of absorbable sutures made from advanced synthetic materials has improved patient outcomes by reducing the risk of infection and minimizing post-surgical complications.
3 Surgical Sutures Market Restraints
Despite the positive growth outlook, the surgical sutures market faces several challenges and restraints that could impact its expansion. One of the primary challenges is the presence of substitute products. Surgical staples, for instance, offer a faster and more efficient method of wound closure compared to traditional sutures. This has led to increased competition, as healthcare providers may opt for these alternatives based on cost and convenience.
Another significant restraint is the potential for complications associated with the use of surgical sutures. These can include wound infections, allergic reactions, and suture-related complications such as dehiscence (the separation of wound edges). These complications can lead to increased healthcare costs and longer recovery times for patients, potentially limiting the widespread adoption of surgical sutures.
4 Global Surgical Sutures Market Sales and Share by Type in 2024
Absorbable sutures are designed to break down harmlessly in the tissue over time without the need for removal. They are particularly useful in surgeries where the wound requires temporary support, and the body can gradually absorb the suture material. Common materials for absorbable sutures include polyglycolic acid, polylactic acid, polydioxanone, and caprolactone. These sutures are often used in soft tissue approximation and ligation, such as in cardiovascular, ophthalmic, orthopedic, and neurological procedures.
In 2024, the market for absorbable sutures is projected to reach 47041.4 thousand units. This segment is expected to hold a significant share of the overall surgical sutures market, driven by its versatility and suitability for a wide range of surgical applications. The growth of absorbable sutures is further supported by advancements in material science, which have led to the development of sutures with improved strength and absorption profiles. For instance, newer absorbable sutures can maintain their tensile strength for longer periods, providing better support during the critical healing phase.
Non-absorbable sutures, on the other hand, are made from materials that do not break down in the body and must be manually removed after the wound has healed. These sutures are typically used for skin wound closure or in internal environments where absorbable sutures would not suffice. Common materials for non-absorbable sutures include silk, polypropylene, polyester, nylon, and stainless steel. They are particularly useful in surgeries involving high-stress areas, such as the heart or bladder, where long-term support is required.
In 2024, the market for non-absorbable sutures is projected to reach 31391 thousand units. While this segment is smaller compared to absorbable sutures, it remains crucial for specific surgical applications. The demand for non-absorbable sutures is driven by their durability and reliability in providing long-term support. Additionally, advancements in non-absorbable suture technology have led to the development of sutures with improved handling characteristics and reduced tissue reactivity, enhancing their appeal to surgeons.
Table Global Surgical Sutures Market Sales and Share by Type in 2024
Type | Market Sales (K Units) 2024 | Market Share 2024 |
Absorbable Sutures | 47041.4 | 59.98% |
Non-absorbable Sutures | 31391.0 | 40.02% |
5 Global Surgical Sutures Market Sales and Share by Application in 2024
Skin ulcers are wounds that result from the disintegration of tissue, often requiring surgical intervention for proper healing. In 2024, the market for surgical sutures used in treating skin ulcers is projected to reach 7153 thousand units. This segment is driven by the increasing prevalence of chronic conditions such as diabetes, which can lead to the development of skin ulcers. The demand for effective wound closure solutions is particularly high in this application area, as improper treatment can lead to severe complications.
Burns are another significant application area for surgical sutures. Burns can range from minor to severe, with severe burns often requiring surgical excision and skin grafting. In 2024, the market for surgical sutures used in treating burns is expected to reach 8345.2 thousand units. The demand for sutures in this segment is driven by the need for rapid and effective wound closure to prevent infection and promote healing. Advances in suture materials and techniques have led to the development of sutures that are better suited for the unique challenges posed by burn wounds.
Surgical wounds are incisions made during surgical procedures, which often require sutures for closure. This segment is the largest application area for surgical sutures, with a projected market size of 44149.6 thousand units in 2024. The demand for sutures in surgical wounds is driven by the increasing number of surgical procedures performed globally. This includes a wide range of surgeries, from routine procedures to complex operations. The choice of suture type (absorbable or non-absorbable) depends on the specific requirements of the surgery and the surgeon’s preference.
Table Global Surgical Sutures Market Sales and Share by Application in 2024
Application | Market Sales (K Units) 2024 | Market Share 2024 |
Skin Ulcers | 7153.0 | 9.12% |
Burns | 8345.2 | 10.64% |
Surgical Wounds | 44149.6 | 56.29% |
Traumatic Wounds | 12125.7 | 15.46% |
Others | 6658.9 | 8.49% |
6 Global Surgical Sutures Market Size by Region in 2024
North America is a significant market for surgical sutures, driven by advanced healthcare infrastructure and high demand for premium medical devices. In 2024, the market for surgical sutures in North America is projected to reach 26020.3 thousand units. The United States is the largest market within this region, accounting for the majority of the demand. The growth in this region is supported by increasing healthcare spending, the presence of major medical device manufacturers, and a growing aging population.
Europe is another key market for surgical sutures, with a projected market size of 20780.2 thousand units in 2024. The region is characterized by advanced healthcare systems and a high demand for high-quality medical devices. Germany, the UK, and France are the largest markets within Europe. The growth in this region is driven by increasing surgical procedures, advancements in medical technology, and supportive government policies.
The Asia-Pacific region is emerging as a significant market for surgical sutures, driven by increasing healthcare spending and a growing aging population. In 2024, the market for surgical sutures in the Asia-Pacific region is projected to reach 29002.3 thousand units. China and Japan are the largest markets within this region. The growth in this region is also supported by the expansion of medical tourism and the increasing adoption of advanced medical technologies.
Figure Global Surgical Sutures Market Sales by Region in 2024
7 Major Players in Global Surgical Sutures Market
7.1 Johnson & Johnson
Company Profile:
Johnson & Johnson is a leading multinational corporation that specializes in the research, development, and production of a wide range of healthcare products. Established in 1886, the company operates through three segments: Consumer, Pharmaceutical, and Medical Devices. Johnson & Johnson is renowned for its commitment to innovation and improving human health and well-being. The company’s manufacturing facilities are spread across North America, Europe, and Asia, ensuring a global market distribution.
Business Overview:
Johnson & Johnson’s Medical Devices segment is particularly notable for its surgical sutures. The company offers a comprehensive range of sutures, including both absorbable and non-absorbable types. Their products are designed to meet the diverse needs of surgical procedures, from routine operations to complex surgeries. Johnson & Johnson’s surgical sutures are known for their high quality, reliability, and innovative features, such as the PROLENE® Polypropylene Suture with HEMO-SEAL™ Technology, which significantly reduces needle hole bleeding and enhances surgical visibility.
Products Analysis:
Johnson & Johnson’s surgical sutures portfolio includes a variety of products tailored to different surgical requirements. The PROLENE® suture, for instance, is a non-absorbable suture that provides excellent knot security and is widely used in cardiovascular and general surgeries. The company also offers absorbable sutures like VICRYL® and MONOCRYL®, which are designed to break down harmlessly in the body over time. These sutures are used in soft tissue approximation and ligation, offering surgeons a reliable and versatile option for wound closure.
Recent Financial Performance:
In the most recent year, Johnson & Johnson’s surgical sutures segment reported a revenue of $2,448.2 million.
7.2 Medtronic plc
Company Profile:
Medtronic plc is a global leader in medical technology, offering a wide range of products and solutions for various medical conditions. Established in 1949, Medtronic operates in several key areas, including cardiac rhythm disorders, cardiovascular disease, surgical care, and neurological disorders. The company’s commitment to innovation and improving patient outcomes has solidified its reputation as a trusted provider of medical devices. Medtronic’s manufacturing facilities are located in North America, Europe, and Asia, ensuring a robust global market presence.
Business Overview:
Medtronic’s surgical care segment includes a diverse portfolio of surgical sutures. The company focuses on developing advanced sutures that enhance surgical outcomes and patient recovery. Medtronic’s products are designed to meet the highest standards of quality and reliability, making them a preferred choice for surgeons worldwide. The company’s commitment to innovation is evident in its continuous development of new suture materials and techniques that improve wound closure and reduce the risk of complications.
Products Analysis:
Medtronic’s surgical sutures portfolio includes both absorbable and non-absorbable sutures. One of their notable products is the Velosorb™ Fast Braided Absorbable Suture, which offers pliable handling, strong wound approximation, and fast absorption. This suture is particularly useful in soft tissue approximation and ligation, providing surgeons with a reliable and efficient option for wound closure. Medtronic also offers non-absorbable sutures like the PROLENE® suture, which is known for its durability and knot security.
Recent Financial Performance:
In the most recent year, Medtronic’s surgical sutures segment reported a revenue of $434.1 million.
7.3 B. Braun Melsungen AG
Company Profile:
B. Braun Melsungen AG is a leading global provider of healthcare products and services. Established in 1839, the company offers a wide range of products for intensive care units, anesthesia, emergency care, and surgical procedures. B. Braun is known for its commitment to innovation and improving patient outcomes. The company’s manufacturing facilities are located in North America, Europe, and Asia, ensuring a robust global market presence.
Business Overview:
B. Braun’s surgical sutures segment includes a comprehensive portfolio of products designed to meet the diverse needs of surgical procedures. The company focuses on developing advanced sutures that enhance surgical outcomes and patient recovery. B. Braun’s products are known for their high quality, reliability, and innovative features, making them a preferred choice for surgeons worldwide. The company’s commitment to innovation is evident in its continuous development of new suture materials and techniques that improve wound closure and reduce the risk of complications.
Products Analysis:
B. Braun’s surgical sutures portfolio includes both absorbable and non-absorbable sutures. One of their notable products is the Monosyn® suture, which is a sterile synthetic absorbable monofilament suture. This suture is designed to provide strong wound approximation and is particularly useful in soft tissue approximation and ligation. B. Braun also offers non-absorbable sutures like the Prolene® suture, which is known for its durability and knot security.
Recent Financial Performance:
In the most recent year, B. Braun’s surgical sutures segment reported a revenue of $248.6 million.